Kenneth A. Foon

13.9k total citations · 3 hit papers
190 papers, 10.3k citations indexed

About

Kenneth A. Foon is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Kenneth A. Foon has authored 190 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Immunology, 70 papers in Radiology, Nuclear Medicine and Imaging and 57 papers in Pathology and Forensic Medicine. Recurrent topics in Kenneth A. Foon's work include Monoclonal and Polyclonal Antibodies Research (65 papers), Lymphoma Diagnosis and Treatment (56 papers) and Chronic Lymphocytic Leukemia Research (51 papers). Kenneth A. Foon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (65 papers), Lymphoma Diagnosis and Treatment (56 papers) and Chronic Lymphocytic Leukemia Research (51 papers). Kenneth A. Foon collaborates with scholars based in United States, Germany and Switzerland. Kenneth A. Foon's co-authors include Robert F. Todd, Fiona E. Craig, C. Darrell Jennings, Malaya Bhattacharya‐Chatterjee, Richard J. Kryscio, Roy A. Patchell, Byron Young, Phillip A. Tibbs, William R. Markesbery and William F. Regine and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Kenneth A. Foon

184 papers receiving 9.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

1997 1.4k citations Kenneth A. Foon et al. Blood profile →
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1998 1.3k citations Kenneth A. Foon et al. PubMed profile →
Immunologic classification of leukemia and lymphoma.

1986 636 citations Kenneth A. Foon et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth A. Foon United States	44	3.5k	3.5k	3.2k	2.6k	2.4k	190	10.3k
Peter Vandenberghe Belgium	58	2.7k 0.8×	2.2k 0.6×	1.6k 0.5×	2.4k 0.9×	986 0.4×	229	10.7k
Håkan Mellstedt Sweden	51	5.4k 1.5×	3.5k 1.0×	2.8k 0.9×	2.2k 0.8×	1.5k 0.6×	298	9.9k
Marinus H. J. van Oers Netherlands	53	3.2k 0.9×	2.8k 0.8×	2.4k 0.7×	2.8k 1.1×	940 0.4×	175	9.0k
Livio Trentin Italy	49	3.6k 1.0×	1.9k 0.5×	2.4k 0.8×	2.5k 0.9×	682 0.3×	332	8.6k
Arnold S. Freedman United States	50	3.8k 1.1×	3.4k 1.0×	2.5k 0.8×	3.8k 1.4×	981 0.4×	188	9.7k
Kensei Tobinai Japan	49	5.0k 1.4×	5.8k 1.7×	2.4k 0.7×	7.3k 2.8×	1.1k 0.5×	425	13.7k
Raymond R. Tubbs United States	59	1.7k 0.5×	4.7k 1.3×	1.2k 0.4×	2.6k 1.0×	1.4k 0.6×	276	10.8k
Wolfram Brugger Germany	51	3.7k 1.0×	4.7k 1.3×	1.9k 0.6×	2.2k 0.8×	543 0.2×	191	10.6k
Jeffrey Cossman United States	46	2.9k 0.8×	2.9k 0.8×	2.4k 0.7×	3.4k 1.3×	842 0.4×	112	9.3k
Irwin D. Bernstein United States	72	4.1k 1.2×	4.6k 1.3×	2.5k 0.8×	2.0k 0.8×	3.8k 1.6×	251	17.5k

Countries citing papers authored by Kenneth A. Foon

Since Specialization

Citations

This map shows the geographic impact of Kenneth A. Foon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth A. Foon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth A. Foon more than expected).

Fields of papers citing papers by Kenneth A. Foon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth A. Foon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth A. Foon. The network helps show where Kenneth A. Foon may publish in the future.

Co-authorship network of co-authors of Kenneth A. Foon

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth A. Foon. A scholar is included among the top collaborators of Kenneth A. Foon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth A. Foon. Kenneth A. Foon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mato, Anthony R., Christopher R. Flowers, Charles M. Farber, et al.. (2015). Prognostic testing patterns in CLL pts treated in U.S. practices from the Connect CLL registry.. Journal of Clinical Oncology. 33(15_suppl). 7013–7013. 2 indexed citations

Foon, Kenneth A. & Michael Hallek. (2009). Changing paradigms in the treatment of chronic lymphocytic leukemia. Leukemia. 24(3). 500–511. 16 indexed citations

Saha, Asim, et al.. (2008). Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2 induced protective antitumor immunity in mice transgenic for human Her-2. Cancer Research. 68. 5293–5293. 1 indexed citations

Jacobs, Samuel A., Anthony M. Harrison, Steven H. Swerdlow, et al.. (2008). Radioisotopic Localization of 90Yttrium–Ibritumomab Tiuxetan in Patients with CD20+ Non-Hodgkin’s Lymphoma. Molecular Imaging and Biology. 11(1). 39–45. 9 indexed citations

Lee, Je‐Jung, Robbie B. Mailliard, Ravikumar Muthuswamy, Kenneth A. Foon, & Paweł Kaliński. (2007). Generation of alpha-Type-1 Polarized Dendritic Cells as a Potent Immunogen in Patients with Chronic Lymphocytic Leukemia.. Blood. 110(11). 2059–2059. 1 indexed citations

Sehgal, Rajesh, Anastasios Raptis, Mounzer Agha, et al.. (2007). Efficacy of Mitoxantrone and Etoposide in Patients with Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy.. Blood. 110(11). 4385–4385.

Saha, Asim, et al.. (2006). Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu. Breast Cancer Research and Treatment. 104(1). 1–11. 16 indexed citations

Saha, Asim, Sunil K. Chatterjee, Kenneth A. Foon, F. James Primus, & Malaya Bhattacharya‐Chatterjee. (2003). Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.. PubMed. 63(11). 2844–54. 22 indexed citations

Rohatgi, Nitin, et al.. (2002). Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low‐grade follicular lymphomas. American Journal of Hematology. 70(3). 181–185. 6 indexed citations

10.

Baral, Rathindranath, et al.. (2001). Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu. International Journal of Cancer. 92(1). 88–95. 21 indexed citations

11.

Chatterjee, Sunil K., et al.. (2000). Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine. Cancer Immunology Immunotherapy. 49(3). 133–141. 34 indexed citations

12.

Tripathi, Pulak, Hong Qin, Malaya Bhattacharya‐Chatterjee, et al.. (1999). Construction and Characterization of a Chimeric Fusion Protein Consisting of an Anti-idiotype Antibody Mimicking a Breast Cancer-Associated Antigen and the Cytokine GM-CSF. Hybridoma. 18(2). 193–202. 11 indexed citations

13.

Foon, Kenneth A., Louis Vaickus, Steven J. Greenberg, et al.. (1995). Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.. PubMed. 1(11). 1285–94. 28 indexed citations

14.

Vaickus, Louis, et al.. (1993). Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T‐Cell Lymphomaa. Annals of the New York Academy of Sciences. 690(1). 376–377. 12 indexed citations

15.

Vaickus, Louis, Edward D. Ball, & Kenneth A. Foon. (1991). Immune markers in hematologic malignancies. Critical Reviews in Oncology/Hematology. 11(4). 267–297. 34 indexed citations

16.

Goldrosen, Martin H., et al.. (1990). Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.. PubMed. 50(10). 2991–6. 20 indexed citations

17.

Giardina, S L, Robert W. Schroff, Thomas J. Kipps, et al.. (1985). The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.. The Journal of Immunology. 135(1). 653–658. 18 indexed citations

18.

Foon, Kenneth A., Jeffrey L. Rossio, Robert W. Schroff, et al.. (1985). The Generation of Stable Human T-Cell Hybridomas Which Constitutively Produce Interleukin-2 and Chemotactic Factor. Hybridoma. 4(3). 211–222. 1 indexed citations

19.

Bernhard, Michael, et al.. (1984). Correspondence re: M. I. Bemhard, K. M. Hwang, K. A. Foon, A. M. Keenan, R. M. Kessler, J. M. Frincke, D. J. Tallam, M. G. Hanna, Jr., L. Peters, and R. K. Oldham. Localization of 111In- and 125I-labeled Monoclonal Antibody in Guinea Pigs Bearing Line 10 Hepatocarcinoma Tumors. Cancer Res., 43: 4429–4433, 1983–Reply. Cancer Research. 44(6). 2731–2732. 1 indexed citations

20.

Foon, Kenneth A., Andrew E. Filderman, & Robert Peter Gale. (1981). Histiocytic lymphoma following resolution of sarcoidosis. Medical and Pediatric Oncology. 9(4). 325–331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact